Surprising finding could lead to new treatment for cystic fibrosis
The surprising finding that people with cystic fibrosis (CF) produce too little airway mucus – rather than too much, as it commonly believed – could lead to more effective treatments for the genetic disorder, say researchers at Wake Forest Baptist Medical Center. "It has always been thought, but never proven, that CF causes the body to produce too much abnormally thick mucus that accumulates in the lungs and intestines," said Bruce Rubin, M.D., professor of pediatrics. "However, we have now shown that these patients actually have very little mucus in their airways. This finding could change the way we think about CF treatment." The research is reported online today in the American Journal of Respiratory Cell and Molecular Biology.
CF is a genetic disease that affects about 40,000 children and adults in the United States. The disease is characterized by frequent respiratory infections, breathing difficulties, and eventually, permanent lung damage. Physicians have always believed that the airways fill with mucus, which normally lubricates and protects the respiratory system. Because people with CF have chronic cough and infection it has long been assumed that the airways were full of mucus.
Rubin and colleagues, however, have shown otherwise. They collected sputum from 12 patients with CF and 11 participants without lung disease and analyzed the contents. Participants with CF had significantly less (70 percent and 93 percent) of two proteins that form mucus than participants with healthy lungs. "This showed unequivocally there is much less mucus in the CF airway," said Rubin, a pediatric pulmonologist at Wake Forest Baptist’s Brenner Children’s Hospital.
The research was conducted by Markus Henke, M.D., while he was completing a fellowship at Wake Forest Baptist in Rubin’s laboratory. He is now at Philipps-University in Marburg, Germany. Henke has since analyzed the sputum from 35 CF patients and said the results are consistent with the earlier findings.
The researchers have shown that the substance clogging the lungs of CF patients is actually pus. They suspect that the airway in CF patients is chronically infected and that it fills with pus. They also suspect that mucus may actually protect the airway from infection. To test their theory, they will conduct a study in animals to determine if mucus can effectively "soak up" the bacteria that they believe is reproducing in the airway of CF patients.
"If it turns out that mucus is protective against the bacteria, we may have a treatment for CF," said Rubin. "We believe that by increasing the mucus in the airway early on, it may help prevent the infection. This certainly wouldn’t be a cure for CF, but it would make a wonderful difference in quality of life while a cure is being sought." Henke stressed that the finding applies to patients who are stable, and not having a flare-up of their disease that requires hospitalization.
Rubin said that if the animal research proves effective, treatment in humans might be available in the next five years. "There are ways to increase mucus production in normal airways, we just need to show that they are also effective in CF airways," he said.
The research was funded by the Cystic Fibrosis Foundation.
Rubin is the author of "Therapy for Mucus Clearance Disorders," published by Dekker/NIH as part of a series on the biology of the lungs.
Shannon Koontz | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
Layered 2D material improves efficiency for solar cells and LEDs
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...